|
|
Volumn 20, Issue 3, 1995, Pages 189-201
|
|
Management of the immunobullous disorders. I. Pemphigoid
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALUMINUM MAGNESIUM HYDROXIDE;
ANTIINFECTIVE AGENT;
AZATHIOPRINE;
BECLOMETASONE;
BECLOMETASONE DIPROPIONATE;
BENZYDAMINE;
BETAMETHASONE SODIUM PHOSPHATE;
BETAMETHASONE VALERATE;
BUDESONIDE;
CHLORTETRACYCLINE;
CLIOQUINOL;
CLOBETASOL PROPIONATE;
CORTICOSTEROID;
CRYSTAL VIOLET;
CYCLOPHOSPHAMIDE;
DAPSONE;
DIPHENHYDRAMINE;
FLUOCINONIDE;
HEXETIDINE;
HEXITIDINE;
IMMUNOGLOBULIN;
LIDOCAINE;
METHOTREXATE;
METHYL GREEN;
NYSTATIN;
PREDNISOLONE;
PREDNISOLONE ACETATE;
PREDNISOLONE SODIUM PHOSPHATE;
PREDNISONE;
RETINOIC ACID;
SULFONAMIDE;
TETRACOSACTIDE;
TETRACYCLINE DERIVATIVE;
TRIAMCINOLONE ACETONIDE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
HUMAN;
PEMPHIGOID;
PRIORITY JOURNAL;
REVIEW;
ADMINISTRATION, ORAL;
ADMINISTRATION, TOPICAL;
ANTI-INFLAMMATORY AGENTS, STEROIDAL;
DRUG ADMINISTRATION SCHEDULE;
HUMAN;
PEMPHIGOID, BULLOUS;
SKIN DISEASES, VESICULOBULLOUS;
SUPPORT, NON-U.S. GOV'T;
|
|
EID: 0029015998
PISSN: 03076938
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1365-2230.1995.tb01301.x Document Type: Review |
|
Times cited : (33)
|
|
References (0)
|
